Frost & Sullivan has found that the U.S. Antimicrobial Coatings Markets earned revenues of $175.4 million in 2005 and estimates this to reach $558.7 million in 2012. The market expects to grow with the increasing need to address microbial growth in end application markets like healthcare and mold remediation markets.
There is an overwhelming need to stop the hospital-acquired infection rates in the U.S., which is a serious cause of concern in the healthcare industry, according to Frost & Sullivan. The ability of antimicrobial coatings to address the above stated concern expects to offer good growth opportunities, the analysis said.
"An increasing pressure to resist the hospital-acquired infection rates is expected to play a crucial role in the growth of this market in the medical domain with its usage in wound dressings and catheters," said Rajesh Varadarajan, Frost & Sullivan research analyst. "Antimicrobial coatings is increasingly seen to ensure good indoor air quality with its presence in HVAC equipments and in mold remediation market to subside mold formation."
The market is witnessing products by companies that have not lived up to the claims earlier promised, the company said. This affects the market because OEMs question the efficacy of product performance.